Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor

Clinical trial NCT01212341 · COMPLETED

Trial details

NCT number: NCT01212341
Sponsor: Seoul National University Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Lymphomas Solid Tumors

Start date: 2010-09-01
Primary completion: 2012-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.